{"id":1332,"date":"2021-11-01T02:30:20","date_gmt":"2021-11-01T02:30:20","guid":{"rendered":"https:\/\/prismbiolab.com\/?post_type=news&p=1332"},"modified":"2022-01-05T04:38:05","modified_gmt":"2022-01-05T09:38:05","slug":"prism-biolab-raised-100-million-yen-in-series-c-funding-from-eisai","status":"publish","type":"news","link":"https:\/\/prismbiolab.com\/ja\/news\/prism-biolab-raised-100-million-yen-in-series-c-funding-from-eisai\/","title":{"rendered":"\u682a\u5f0f\u4f1a\u793ePRISM BioLab\u3001\u30a8\u30fc\u30b6\u30a4\u682a\u5f0f\u4f1a\u793e\u3088\u308a\u8cc7\u91d1\u8abf\u9054"},"content":{"rendered":"

\u682a\u5f0f\u4f1a\u793ePRISM BioLab\u306f\u300110\u670812\u65e5\u4ed8\u3067\u3001\u30a8\u30fc\u30b6\u30a4\u682a\u5f0f\u4f1a\u793e\u3092\u5f15\u53d7\u5148\u3068\u3057\u305f\u7b2c\u4e09\u8005\u5272\u5f53\u5897\u8cc7\u306b\u3088\u308a1\u5104\u5186\u306e\u30b7\u30ea\u30fc\u30baC\u8cc7\u91d1\u8abf\u9054\u3092\u5b9f\u65bd\u3044\u305f\u3057\u307e\u3057\u305f\u3002\u3053\u308c\u306b\u3088\u308a\u3001\u7dcf\u984d14\u5104\u5186\u306e\u30b7\u30ea\u30fc\u30baC\u8cc7\u91d1\u8abf\u9054\u306f\u5b8c\u4e86\u3057\u3001\u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u306e\u524d\u81e8\u5e8a\u8a66\u9a13\u3084\u7814\u7a76\u958b\u767a\u53ca\u3073\u5185\u90e8\u7d71\u5236\u4f53\u5236\u306e\u5f37\u5316\u306b\u3088\u308a\u3055\u3089\u306a\u308b\u6210\u9577\u3092\u76ee\u6307\u3057\u307e\u3059\u3002<\/p>\n

<\/i> \u8a73\u7d30\u306f\u3053\u3061\u3089<\/a><\/p>","protected":false},"excerpt":{"rendered":"

PRISM BioLab, the Japan based biotechnology company with proprietary small molecule drug discovery technology \u201dPepMetics\u00ae\u201d, today announced that it has raised \u00a5100 million in Series C funding through a third-party allotment to Eisai Co. Ltd. on October 14. PRISM has completed the series C financing of 1.4 billion yen in total and aims to achieve […]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","template":"","tags":[],"news-category":[8],"class_list":["post-1332","news","type-news","status-publish","hentry","news-category-news","post"],"yoast_head":"\nPRISM BioLab raised 100 million yen in Series C funding from Eisai - PRISM BioLab<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/prismbiolab.com\/ja\/news\/prism-biolab-raised-100-million-yen-in-series-c-funding-from-eisai\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PRISM BioLab raised 100 million yen in Series C funding from Eisai - PRISM BioLab\" \/>\n<meta property=\"og:description\" content=\"PRISM BioLab, the Japan based biotechnology company with proprietary small molecule drug discovery technology \u201dPepMetics\u00ae\u201d, today announced that it has raised \u00a5100 million in Series C funding through a third-party allotment to Eisai Co. Ltd. on October 14. PRISM has completed the series C financing of 1.4 billion yen in total and aims to achieve […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/prismbiolab.com\/ja\/news\/prism-biolab-raised-100-million-yen-in-series-c-funding-from-eisai\/\" \/>\n<meta property=\"og:site_name\" content=\"PRISM BioLab\" \/>\n<meta property=\"article:modified_time\" content=\"2022-01-05T09:38:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/prismbiolab.com\/wp-content\/uploads\/2024\/07\/career-collage.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1122\" \/>\n\t<meta property=\"og:image:height\" content=\"1097\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data1\" content=\"1\u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/prismbiolab.com\\\/news\\\/prism-biolab-raised-100-million-yen-in-series-c-funding-from-eisai\\\/\",\"url\":\"https:\\\/\\\/prismbiolab.com\\\/news\\\/prism-biolab-raised-100-million-yen-in-series-c-funding-from-eisai\\\/\",\"name\":\"PRISM BioLab raised 100 million yen in Series C funding from Eisai - PRISM BioLab\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/prismbiolab.com\\\/#website\"},\"datePublished\":\"2021-11-01T02:30:20+00:00\",\"dateModified\":\"2022-01-05T09:38:05+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/prismbiolab.com\\\/news\\\/prism-biolab-raised-100-million-yen-in-series-c-funding-from-eisai\\\/#breadcrumb\"},\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/prismbiolab.com\\\/news\\\/prism-biolab-raised-100-million-yen-in-series-c-funding-from-eisai\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/prismbiolab.com\\\/news\\\/prism-biolab-raised-100-million-yen-in-series-c-funding-from-eisai\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/prismbiolab.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/prismbiolab.com\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"PRISM BioLab raised 100 million yen in Series C funding from Eisai\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/prismbiolab.com\\\/#website\",\"url\":\"https:\\\/\\\/prismbiolab.com\\\/\",\"name\":\"PRISM BioLab\",\"description\":\"PRISM BioLab MIMICS natural peptides leading to cures of the greatest health challenges\",\"publisher\":{\"@id\":\"https:\\\/\\\/prismbiolab.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/prismbiolab.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ja\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/prismbiolab.com\\\/#organization\",\"name\":\"PRISM BioLab\",\"url\":\"https:\\\/\\\/prismbiolab.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/prismbiolab.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/prismbiolab.com\\\/wp-content\\\/uploads\\\/2021\\\/09\\\/prism_logo_b.jpg\",\"contentUrl\":\"https:\\\/\\\/prismbiolab.com\\\/wp-content\\\/uploads\\\/2021\\\/09\\\/prism_logo_b.jpg\",\"width\":300,\"height\":367,\"caption\":\"PRISM BioLab\"},\"image\":{\"@id\":\"https:\\\/\\\/prismbiolab.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"PRISM BioLab raised 100 million yen in Series C funding from Eisai - PRISM BioLab","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/prismbiolab.com\/ja\/news\/prism-biolab-raised-100-million-yen-in-series-c-funding-from-eisai\/","og_locale":"ja_JP","og_type":"article","og_title":"PRISM BioLab raised 100 million yen in Series C funding from Eisai - PRISM BioLab","og_description":"PRISM BioLab, the Japan based biotechnology company with proprietary small molecule drug discovery technology \u201dPepMetics\u00ae\u201d, today announced that it has raised \u00a5100 million in Series C funding through a third-party allotment to Eisai Co. Ltd. on October 14. PRISM has completed the series C financing of 1.4 billion yen in total and aims to achieve […]","og_url":"https:\/\/prismbiolab.com\/ja\/news\/prism-biolab-raised-100-million-yen-in-series-c-funding-from-eisai\/","og_site_name":"PRISM BioLab","article_modified_time":"2022-01-05T09:38:05+00:00","og_image":[{"width":1122,"height":1097,"url":"https:\/\/prismbiolab.com\/wp-content\/uploads\/2024\/07\/career-collage.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"1\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/prismbiolab.com\/news\/prism-biolab-raised-100-million-yen-in-series-c-funding-from-eisai\/","url":"https:\/\/prismbiolab.com\/news\/prism-biolab-raised-100-million-yen-in-series-c-funding-from-eisai\/","name":"PRISM BioLab raised 100 million yen in Series C funding from Eisai - PRISM BioLab","isPartOf":{"@id":"https:\/\/prismbiolab.com\/#website"},"datePublished":"2021-11-01T02:30:20+00:00","dateModified":"2022-01-05T09:38:05+00:00","breadcrumb":{"@id":"https:\/\/prismbiolab.com\/news\/prism-biolab-raised-100-million-yen-in-series-c-funding-from-eisai\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/prismbiolab.com\/news\/prism-biolab-raised-100-million-yen-in-series-c-funding-from-eisai\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/prismbiolab.com\/news\/prism-biolab-raised-100-million-yen-in-series-c-funding-from-eisai\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/prismbiolab.com\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/prismbiolab.com\/news\/"},{"@type":"ListItem","position":3,"name":"PRISM BioLab raised 100 million yen in Series C funding from Eisai"}]},{"@type":"WebSite","@id":"https:\/\/prismbiolab.com\/#website","url":"https:\/\/prismbiolab.com\/","name":"PRISM BioLab","description":"PRISM BioLab MIMICS natural peptides leading to cures of the greatest health challenges","publisher":{"@id":"https:\/\/prismbiolab.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/prismbiolab.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/prismbiolab.com\/#organization","name":"PRISM BioLab","url":"https:\/\/prismbiolab.com\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/prismbiolab.com\/#\/schema\/logo\/image\/","url":"https:\/\/prismbiolab.com\/wp-content\/uploads\/2021\/09\/prism_logo_b.jpg","contentUrl":"https:\/\/prismbiolab.com\/wp-content\/uploads\/2021\/09\/prism_logo_b.jpg","width":300,"height":367,"caption":"PRISM BioLab"},"image":{"@id":"https:\/\/prismbiolab.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/prismbiolab.com\/ja\/wp-json\/wp\/v2\/news\/1332","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/prismbiolab.com\/ja\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/prismbiolab.com\/ja\/wp-json\/wp\/v2\/types\/news"}],"author":[{"embeddable":true,"href":"https:\/\/prismbiolab.com\/ja\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/prismbiolab.com\/ja\/wp-json\/wp\/v2\/comments?post=1332"}],"version-history":[{"count":1,"href":"https:\/\/prismbiolab.com\/ja\/wp-json\/wp\/v2\/news\/1332\/revisions"}],"predecessor-version":[{"id":1353,"href":"https:\/\/prismbiolab.com\/ja\/wp-json\/wp\/v2\/news\/1332\/revisions\/1353"}],"wp:attachment":[{"href":"https:\/\/prismbiolab.com\/ja\/wp-json\/wp\/v2\/media?parent=1332"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/prismbiolab.com\/ja\/wp-json\/wp\/v2\/tags?post=1332"},{"taxonomy":"news-category","embeddable":true,"href":"https:\/\/prismbiolab.com\/ja\/wp-json\/wp\/v2\/news-category?post=1332"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}